(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

WHITE DRUG PHARMACY RX EST. 1884

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

WHITE DRUG PHARMACY RX EST. 1884

ST13

US500000077018685

Class

35, 40, 41

Filing

77018685

Registration

3310537

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

35

Latest update

06/24/2023

Trademark type

Combined

Nice classes

35, 40, 41

Filing date

10/11/2006

Registration date

10/16/2007

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/11/2017

Last transaction

06/24/2023

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

2003-08-00

First use in commerce

2003-08-00

Drawing code

3

Owner type

03

Owner location

Plymouth, MN, US

Examiner

BUJA, SANDRA

Law office

L40

Current location

TMEG LAW OFFICE 104

Mark description

The mark consists of mortar and pestle with the letters Rx on the mortar.

Holders and representatives

Holders

Thrifty Drug Stores, Inc.
Thrifty Drug Stores, Inc.

Representatives

Cynthia A. Moyer FREDRIKSON & BYRON, P.A.

Technical classification

Nice Classes

Class 35Class 40Class 41

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Retail pharmacy and drug store services; retail store services featuring general consumer merchandise

Class 40

Photo processing services

Class 41

Photography services

Publications

History of USPTO decisions and trademark events.

35 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/16/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/16/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/16/2023

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

11/11/2017

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

11/11/2017

9G8P

REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8

11/11/2017

8PRT

REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED

11/11/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/11/2017

E89R

TEAS SECTION 8 & 9 RECEIVED

10/16/2017

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

10/16/2016

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

11/27/2012

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

11/27/2012

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/27/2012

E815

TEAS SECTION 8 & 15 RECEIVED

10/31/2012

R.PR

REGISTERED-PRINCIPAL REGISTER

10/16/2007

ISIR

WITHDRAWN FROM ISSUE - TQR/NON-ATTY REQUEST

09/04/2007

PUBO

PUBLISHED FOR OPPOSITION

07/10/2007

NPUB

NOTICE OF PUBLICATION

06/20/2007

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

06/06/2007

ALIE

ASSIGNED TO LIE

05/30/2007

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/30/2007

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/23/2007

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/23/2007

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/11/2007

ACEC

AMENDMENT FROM APPLICANT ENTERED

05/03/2007

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/03/2007

MAIL

PAPER RECEIVED

05/01/2007

GPRA

PRIORITY ACTION E-MAILED

03/01/2007

CPRA

PRIORITY ACTION WRITTEN

03/01/2007

DOCK

ASSIGNED TO EXAMINER

02/27/2007

AMPX

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

12/13/2006

ALIE

ASSIGNED TO LIE

12/01/2006

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

11/11/2006

MDSM

NOTICE OF DESIGN SEARCH CODE MAILED

10/17/2006

NWAP

NEW APPLICATION ENTERED

10/16/2006

Continuous trademark protection

Get notified about every new filing that threatens WHITE DRUG PHARMACY RX EST. 1884 or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.